Correlation Between Praxis Precision and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and DiaMedica Therapeutics, you can compare the effects of market volatilities on Praxis Precision and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and DiaMedica Therapeutics.
Diversification Opportunities for Praxis Precision and DiaMedica Therapeutics
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Praxis and DiaMedica is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Praxis Precision i.e., Praxis Precision and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Praxis Precision and DiaMedica Therapeutics
Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 1.13 times more return on investment than DiaMedica Therapeutics. However, Praxis Precision is 1.13 times more volatile than DiaMedica Therapeutics. It trades about 0.17 of its potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.19 per unit of risk. If you would invest 5,538 in Praxis Precision Medicines on September 3, 2024 and sell it today you would earn a total of 2,479 from holding Praxis Precision Medicines or generate 44.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Praxis Precision Medicines vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Praxis Precision Med |
| DiaMedica Therapeutics |
Praxis Precision and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Praxis Precision and DiaMedica Therapeutics
The main advantage of trading using opposite Praxis Precision and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Praxis Precision vs. DiaMedica Therapeutics | Praxis Precision vs. Lyra Therapeutics | Praxis Precision vs. Centessa Pharmaceuticals PLC |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |